London, 15 December 2016: Private equity fund manager and Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) specialist Calculus Capital has invested £3m in UK trampoline park company Jumptastic as it plans to expand into Scandinavia. Jumptastic’s highly successful first park opened in Gloucester in 2015, offering 90 interlinked trampolines over 30,000 square feet. The … Continued
Calculus Capital’s portfolio company Synpromics, the leading synthetic promoter and gene control company, has announced the expansion of the research collaboration with Adverum Biotechnologies that began in December 2015. The initial collaboration focused on using Synpromics technology to develop promoters for the treatment of eye diseases, and has yielded promising early results. The new research … Continued
John Glencross, CEO of Calculus Capital is cited in the FT’s latest VCT article. Investors face missing out on lucrative tax breaks as popular venture capital trusts cut yearly fundraising levels, warn wealth managers. Jason Hollands, managing director at Tilney Bestinvest, said there was an ongoing “supply crunch” around the funds, which offer investors 30 … Continued
Venn Life Sciences has signed a new contract worth €2.5m with Sedana Medical for a phase III trial. The trial, which is confined to patients in Germany and commences immediately, will confirm the efficacy and safety of sedation with isoflurane in ventilated intensive care patients. Sedana Medical is based in Sweden with operations across Europe, … Continued
Punter Southall Aspire appoints online technology provider Quai as administrator for its forthcoming master trust Punter Southall Aspire has selected Quai Administration Services as the out-sourced investment administrator for its forthcoming Master Trust. The firm has also made a strategic investment in Quai, as it continues its approach of taking stakes in service provider partners, … Continued
NHS to adopt NIPT for high risk women Manchester, UK – 31 October 2016: Premaitha Health plc (AIM: NIPT), developer of the leading CE-marked complete non-invasive prenatal screening system, welcomes the decision by the UK’s Department of Health to make non-invasive prenatal tests (“NIPT”) routinely available on the NHS to high risk* pregnant women across … Continued
London, 4th November 2016 Calculus Capital, the private equity fund manager and Enterprise Investment Scheme and VCT specialist, was named Best EIS Investment Manager in the Growth Investor Awards 2016. The awards, which were announced on Thursday 3rd November, recognise the achievements of those enabling ‘scale-up’ businesses to realise their full potential and drive Britain’s … Continued
The Liverpool Echo cover Arcis Biotechnology’s latest development: A Daresbury bio-tech firm has announced the launch of a kit for preparing DNA extracted from blood. Arcis Biotechnology said the process takes three minutes and uses a novel two-step system sold in a ready-to-use format. A spokesman for the company said it enables users to stabilise … Continued
HMRC Key EIS Statistics – October 2016 Today, the government released the latest statistics on the Enterprise Investment Scheme and companies raising funds through the scheme. Enterprise Investment Scheme Since the Enterprise Investment Scheme (EIS) was launched in 1993-94, over 24,620 individual companies have received investment through the scheme and almost £14.2 billion of funds … Continued
Calculus Capital has been shortlisted for two accolades in the inaugural Investment Week Tax Efficiency Awards. Calculus is one of just four firms shortlisted in the Best Generalist Venture Capital Trust (VCT) category, and is also in the running for Best Generalist Enterprise Investment Scheme (EIS) provider. Investment Week comments: changes to the pensions regime in the UK have … Continued